S&P 500 7,357.49 â–ŧ 0.73 (-0.01%) DOW 51,920.62 ▲ 71.72 (+0.14%) NASDAQ 25,358.60 â–ŧ 118.03 (-0.46%) US Markets Closed â€ĸ 03:19 AM ET

JRSS

JRSIS Health Care Corporation

Price Chart
Latest Quote

$0.03

+0.00 (+0.00%)
Current Price
Previous Close $0.03
Open $0.03
Day High $0.03
Day Low $0.02
Volume 99,991
Fetched: 2026-06-26T07:19:00
Stock Information
Shares Outstanding 84.60M
Total Debt $1.34M
Cash Equivalents $1K
Revenue $3.47M
Net Income $-490K
Sector Consumer Cyclical
Industry Specialty Retail
Market Cap $2.49M
EPS (TTM) $-0.29
Exchange OID
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$3.79M
Sales$3.47M
Income$-490K
Book/sh$-0.00
Cash/sh$0.00
Employees36
Financial Ratios
Quick Ratio0.59
Current Ratio0.78
Returns & Margins
ROA-32.02%
ROE-478.87%
Gross Margin12.74%
Operating Margin-92.49%
Profit Margin-14.12%
Ownership
Insider Ownership96.30%
Insider & Institutional transactions data not available
Valuation Ratios
P/S0.72
P/B-14.70
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.05
SMA50$0.03
SMA200$0.02
RSI5.14
ATR0.0093
Shares Float3.13M
Volatility0.51
Performance History
Week+0.00%
Month+119.40%
Quarter+194.00%
6 Months+27.83%
YTD+62.43%
Year+33.03%
3 Years-95.80%
5 Years-99.21%
10 Years-99.50%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-25 $0.03 0
2026-06-24 $0.03 0
2026-06-23 $0.03 0
2026-06-22 $0.03 0
2026-06-18 $0.03 0
2026-06-17 $0.03 0
2026-06-16 $0.03 0
2026-06-15 $0.03 0
2026-06-12 $0.03 0
2026-06-11 $0.03 0
2026-06-10 $0.03 0
2026-06-09 $0.03 107,089
2026-06-08 $0.02 98,400
2026-06-05 $0.04 4,054,363
2026-06-04 $0.12 62,410
2026-06-03 $0.13 145,460
2026-06-02 $0.09 194,828
2026-06-01 $0.06 17,134
2026-05-29 $0.06 326,845
2026-05-28 $0.04 838,238
2026-05-27 $0.02 824,745
2026-05-26 $0.01 310,000
About JRSIS Health Care Corporation

JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.

📰 Latest News
No news articles available at the moment. Check back later for updates on JRSS.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $1,050,519 $2,978,882 $1,692,919 $20,198,153
Cost Of Revenue $1,050,519 $2,978,882 $1,692,919 $20,198,153
Total Revenue $1,324,863 $3,461,933 $1,719,130 $0
Operating Revenue $1,324,863 $3,461,933 $1,719,130 $0
Expenses
Interest Expense $20,875 $56,443 $64,709 $0
Total Expenses $1,810,863 $3,650,531 $2,403,906 $104,943
Net Non Operating Interest Income Expense $-20,875 $102,985 $-64,709 $0
Interest Expense Non Operating $20,875 $56,443 $64,709 $0
Operating Expense $760,344 $671,649 $710,987 $104,943
Selling And Marketing Expense $323,633 $146,334 $144,651 $35,817
General And Administrative Expense $387,018 $336,049 $283,293 $97,701
Other Income Expense - $156,370 $76,225 $1,142
Other Non Operating Income Expenses - $156,370 $76,225 $266,957
Total Other Finance Cost - - $13,312 -
Other Operating Expenses - - $37,582 $7,242
Rent Expense Supplemental - - - $1,155,662
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-509,790 $-94,588 $-575,839 $-103,801
Net Interest Income $-20,875 $102,985 $-64,709 $0
Normalized Income $-509,790 $-94,588 $-575,839 $-104,943
Net Income From Continuing And Discontinued Operation $-509,790 $-94,588 $-575,839 $3,188,945
Total Operating Income As Reported $-486,000 $-188,598 $-684,776 $-103,801
Net Income Common Stockholders $-509,790 $-94,588 $-575,839 $3,188,945
Net Income $-509,790 $-94,588 $-575,839 $3,188,945
Net Income Including Noncontrolling Interests $-509,790 $-94,588 $-673,260 $3,188,945
Net Income Continuous Operations $-509,790 $-94,588 $-673,260 $-103,801
Pretax Income $-506,875 $-85,613 $-673,260 $-103,801
Operating Income $-486,000 $-188,598 $-684,776 $-104,943
Gross Profit $274,344 $483,051 $26,211 $24,193,018
Interest Income - $102,985 $0 -
Interest Income Non Operating - $102,985 $0 -
Net Income Discontinuous Operations - - $-33,393,670 $3,292,746
Depreciation Amortization Depletion Income Statement - - $5,796 $0
Depreciation And Amortization In Income Statement - - $5,796 $0
Depreciation Income Statement - - $5,796 $0
Per Share
Diluted EPS $-0.10 $0.00 $-0.18 $1.71
Basic EPS $-0.10 $0.00 $-0.18 $1.73
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-449,747 $-130,357 $-563,510 $-104,943
Reconciled Depreciation $36,253 $58,241 $45,041 $0
EBITDA (Bullshit earnings) $-449,747 $-130,357 $-563,510 $-103,801
EBIT $-486,000 $-188,598 $-608,551 $-103,801
Diluted Average Shares $8,459,865 $8,259,410 $3,697,600 $1,866,158
Basic Average Shares $8,459,865 $8,259,410 $3,697,600 $1,845,158
Diluted NI Availto Com Stockholders $-509,790 $-94,588 $-575,839 $3,188,945
Tax Provision $2,915 $8,975 $0 $0
Research And Development $49,693 $189,266 $283,043 -
Selling General And Administration $710,651 $482,383 $427,944 $97,701
Other Gand A $387,018 $336,049 $283,293 $97,701
Minority Interests - $13,676 $97,421 $-956,684
Total Unusual Items - - $7 $1,142
Total Unusual Items Excluding Goodwill - - $7 $1,142
Gain On Sale Of Security - - $7 $1,142
Salaries And Wages - - $260,177 $0
Rent And Landing Fees - - - $1,155,662
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-197,704 $-137,406 $-361,648 $22,067,902
Total Assets $1,232,760 $2,144,525 $2,041,308 $75,692,752
Total Non Current Assets $248,055 $310,635 $377,680 $61,826,821
Other Non Current Assets $248,055 $310,635 - $61,826,821
Current Assets $984,705 $1,833,890 $1,663,628 $13,865,931
Prepaid Assets $131,160 $423,172 $71,554 $2,812,156
Inventory $341,774 $455,240 $562,015 $1,771,158
Receivables $403,256 $837,364 $871,246 $0
Accounts Receivable $400,549 $835,744 $683,452 $7,544,033
Cash Cash Equivalents And Short Term Investments $108,515 $118,114 $158,813 $29,847
Cash And Cash Equivalents $108,515 $118,114 $158,813 $29,847
Cash Financial $108,515 $118,114 - -
Non Current Deferred Assets - $0 $4,576 $2,117,763
Non Current Deferred Taxes Assets - $0 $4,576 -
Goodwill And Other Intangible Assets - $257,334 $303,195 -
Other Intangible Assets - $257,334 $303,195 -
Other Receivables - $3,108 $2,987 $83,685
Taxes Receivable - $51,714 $0 -
Allowance For Doubtful Accounts Receivable - $0 $0 $-3,390,247
Gross Accounts Receivable - $714,658 $683,452 $10,934,280
Assets Held For Sale Current - - $0 $13,836,084
Current Deferred Assets - - $736,393 $0
Non Current Prepaid Assets - - - $967,950
Debt
Net Debt - $908,556 $1,466,676 -
Total Debt - $14,917 $1,659,432 $0
Long Term Debt And Capital Lease Obligation - $24,950 $2,235 $0
Long Term Debt - $24,950 - -
Current Debt And Capital Lease Obligation - $14,917 $1,657,197 $3,306,006
Current Debt - $14,917 $1,625,489 $629,050
Other Current Borrowings - $18,713 $49,709 -
Liabilities
Total Liabilities Net Minority Interest $1,467,259 $2,305,177 $2,109,651 $42,590,572
Total Non Current Liabilities Net Minority Interest $6,311 $24,950 $2,235 $24,991,070
Other Non Current Liabilities $6,311 $24,950 - -
Current Liabilities $1,460,948 $2,280,227 $2,107,416 $17,599,502
Current Notes Payable $0 $14,917 - $629,050
Payables And Accrued Expenses $1,460,948 $2,265,310 $440,089 $1,522,932
Payables $1,460,948 $2,265,310 $440,089 $1,522,932
Accounts Payable $1,460,948 $2,265,310 $275,868 $66,000
Current Deferred Liabilities - $218,313 $10,130 $308,491
Other Payable - $67,963 $90,920 $13
Total Tax Payable - $18,845 $73,301 $420,796
Income Tax Payable - $969 $1,435 -
Liabilities Heldfor Sale Non Current - - $0 $24,991,063
Derivative Product Liabilities - - $0 $7
Non Current Deferred Liabilities - - - $3,993,209
Non Current Deferred Taxes Liabilities - - - $3,993,209
Other Current Liabilities - - - $16,076,570
Current Deferred Taxes Liabilities - - - $308,491
Equity
Common Stock Equity $-197,704 $-137,406 $-58,453 $22,067,902
Total Equity Gross Minority Interest $-234,499 $-160,652 $-68,343 $33,102,180
Stockholders Equity $-197,704 $-137,406 $-58,453 $22,067,902
Gains Losses Not Affecting Retained Earnings $143,071 $142,860 $140,976 $545,449
Other Equity Adjustments $143,071 $142,860 $140,976 $545,449
Retained Earnings $-3,878,945 $-3,442,898 $-3,361,986 $-1,877,296
Other
Ordinary Shares Number $84,598,650 $82,594,105 $5,836,656 $1,862,856
Share Issued $84,598,650 $82,594,105 $5,836,656 $1,862,856
Tangible Book Value $-197,704 $-137,406 $-361,648 $22,067,902
Invested Capital $-197,704 $-122,489 $1,567,036 $22,067,902
Working Capital $-476,243 $-446,337 $-443,788 $-3,733,571
Total Capitalization $-197,704 $-137,406 $-58,453 $22,067,902
Minority Interest $-36,795 $-23,246 $-9,890 $11,034,278
Additional Paid In Capital $3,529,710 $3,154,373 $3,154,881 $23,381,121
Capital Stock $8,460 $8,259 $7,676 $18,628
Common Stock $8,460 $8,259 $7,676 $18,628
Duefrom Related Parties Current $2,707 $1,620 $187,794 $0
Capital Lease Obligations - $42,424 $33,943 $0
Preferred Stock - $0 $0 -
Long Term Capital Lease Obligation - $0 $2,235 $0
Current Deferred Revenue - $218,313 $10,130 -
Current Capital Lease Obligation - $42,424 $31,708 $0
Line Of Credit - $983,007 $1,575,780 -
Current Accrued Expenses - $114,759 $0 -
Dueto Related Parties Current - $14,917 $0 $1,456,919
Net PPE - $53,301 $69,909 $0
Accumulated Depreciation - $-97,552 $-178,602 $0
Gross PPE - $150,853 $248,511 $0
Other Properties - $108,116 $105,084 $14,753,639
Machinery Furniture Equipment - $39,460 $135,741 $0
Buildings And Improvements - $3,277 $7,686 $0
Properties - $0 $0 $0
Inventories Adjustments Allowances - $-188,346 $-237,451 -
Finished Goods - $212,364 $241,099 $1,032,696
Work In Process - $128,900 $229,032 -
Raw Materials - $302,322 $329,335 $738,462
Construction In Progress - - - $3,240,774
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-453,230 $516,724 $-1,764,729 $8,233,016
Operating Activities
Operating Cash Flow $-453,230 $516,724 $-1,764,729 $8,233,016
Cash Flow From Continuing Operating Activities $-453,230 $516,724 $-1,764,729 $-109,241
Operating Gains Losses - $173 $-7 $-1,142
Cash From Discontinued Operating Activities - - $3,171,627 $8,342,256
Investing Activities
Investing Cash Flow $0 $18,885 $0 $-5,500,437
Capital Expenditure - $-1,484 $-44,644 $-5,500,437
Cash Flow From Continuing Investing Activities - $18,885 $0 $0
Cash From Discontinued Investing Activities - - $-2,783,041 $-5,500,437
Financing Activities
Financing Cash Flow $445,011 $-568,365 $1,858,287 $-2,798,024
Cash Flow From Continuing Financing Activities $445,011 $-568,365 $1,858,287 $142,570
Issuance Of Capital Stock - $0 $927,591 $141,428
Net Other Financing Charges - $-14,471 $7 $1,142
Net Common Stock Issuance - $0 $927,591 $141,428
Common Stock Issuance - $0 $927,591 $141,428
Cash From Discontinued Financing Activities - - $-867,508 $-2,940,594
Cash Dividends Paid - - - $0
Other
Issuance Of Debt $445,011 $452,984 $930,696 $2,488,411
End Cash Position $108,515 $118,114 $158,813 $855,971
Beginning Cash Position $118,114 $158,813 $73,253 $844,827
Effect Of Exchange Rate Changes $-1,380 $-7,943 $-7,998 $76,589
Changes In Cash $-8,219 $-32,756 $93,558 $-65,445
Net Issuance Payments Of Debt $445,011 $-568,365 $930,696 $-1,558,833
Net Long Term Debt Issuance $445,011 $452,984 $930,696 $-1,558,833
Long Term Debt Issuance $445,011 $452,984 $930,696 $2,488,411
Change In Working Capital $20,307 $553,071 $-1,135,926 $-4,298
Change In Payables And Accrued Expense $-819,279 $765,462 $22,606 $-4,298
Change In Payable $-819,279 $765,462 $11,604 $-4,298
Change In Account Payable $-804,362 $765,462 $11,257 $-2,000
Change In Prepaid Assets $292,012 $-351,711 $-34,682 $-2,251,130
Change In Inventory $113,466 $128,663 $57,324 $-269,217
Change In Receivables $434,108 $10,657 $-13,715 $0
Changes In Account Receivables $435,195 $-50,854 $-13,715 $-2,989,487
Depreciation Amortization Depletion $36,253 $58,241 $45,041 $0
Depreciation And Amortization $36,253 $58,241 $45,041 $0
Net Income From Continuing Operations $-509,790 $-94,588 $-673,260 $-103,801
Repayment Of Debt - $-1,021,349 $0 $-4,047,244
Interest Paid Supplemental Data - $56,443 $58,524 $1,381,761
Income Tax Paid Supplemental Data - $4,945 $909 $25,275
Net Short Term Debt Issuance - $-1,021,349 $0 -
Short Term Debt Payments - $-1,021,349 $0 -
Net Business Purchase And Sale - $20,369 $0 -
Sale Of Business - $20,369 $0 -
Net Intangibles Purchase And Sale - $0 $0 -
Purchase Of Intangibles - $0 $0 -
Net PPE Purchase And Sale - $18,885 $0 $0
Sale Of PPE - $18,885 - -
Purchase Of PPE - $-1,484 $0 $0
Change In Other Working Capital - $209,031 $-1,167,459 -
Change In Other Current Liabilities - $-5,534 $0 -
Change In Accrued Expense - $114,021 $11,002 $325,365
Change In Tax Payable - $-52,504 $347 $733,811
Change In Income Tax Payable - $-52,504 $347 $733,811
Other Non Cash Items - $225 $325 $1
Asset Impairment Charge - $-42,439 $0 -
Deferred Tax - $4,457 $-909 -
Deferred Income Tax - $4,457 $-909 -
Depreciation - $58,016 $45,041 $0
Gain Loss On Sale Of PPE - $173 - $22,094
Stock Based Compensation - - $245,465 $0
Gain Loss On Investment Securities - - $-7 $-1,142
Interest Paid Cff - - - $-1,381,761
Long Term Debt Payments - - - $-4,047,244
Fetched: 2026-02-02